Skip to content

Clinical trials

Spondylitis, Ankylosing trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Spondylitis, Ankylosing Clear all

516 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20028
20038
200413
200511
200611
200716
200820
200917
201020
201119
201223
201316
201422
201525
201628
201724
201821
201921
202024
202126
202223
202332
202424
202527
202628

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed302
Unknown status81
Recruiting48
Not yet recruiting28
Terminated28
Active, not recruiting13
Withdrawn11
Suspended2
Enrolling by invitation2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals19
Pfizer19
AbbVie15
Wyeth is now a wholly owned subsidiary of Pfizer14
Charite University, Berlin, Germany13
Merck Sharp & Dohme LLC13
AbbVie (prior sponsor, Abbott)10
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)8
Sun Yat-sen University8
Abbott7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Spondylitis, Ankylosing516
Arthritis, Rheumatoid125
Arthritis, Psoriatic100
Spondylarthritis56
Axial Spondyloarthritis55
Crohn Disease39
Arthritis34
Psoriasis31
Spondylarthropathies30
Colitis, Ulcerative28

Trials

Showing 51 to 75 of 516. Each trial links to its page on Pharma Observatory.

416 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.